Name: LOC100128095 | Sequence: fasta or formatted (95aa) | NCBI GI: 239744520 | |
Description: PREDICTED: hypothetical protein isoform 1
| Not currently referenced in the text | ||
Other entries for this name:
alt prot {155aa} PREDICTED: hypothetical protein isoform 2 alt prot {155aa} PREDICTED: hypothetical protein alt prot {155aa} PREDICTED: hypothetical protein | |||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 17.9 17 3 C cysteine 3.2 3 1 D aspartate 4.2 4 2 E glutamate 4.2 4 2 F phenylalanine 3.2 3 1 G glycine 5.3 5 1 H histidine 2.1 2 1 I isoleucine 1.1 1 1 K lysine 1.1 1 1 L leucine 10.5 10 1 M methionine 3.2 3 1 N asparagine 0.0 0 0 P proline 4.2 4 1 Q glutamine 3.2 3 1 R arginine 8.4 8 2 S serine 9.5 9 2 T threonine 8.4 8 1 V valine 10.5 10 1 W tryptophan 0.0 0 0 Y tyrosine 0.0 0 0 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 PREDICTED: hypothetical protein isoform 1 LOC100128095 0.447 PREDICTED: hypothetical protein LOC100128095 0.447 PREDICTED: hypothetical protein LOC100128095 0.447 PREDICTED: hypothetical protein isoform 2 LOC729915 0.019 PREDICTED: similar to Putative POM121-like protein ... LOC100133280 0.019 PREDICTED: similar to Putative POM121-like protein ... FBN3 0.013 fibrillin 3 precursor ARX 0.013 aristaless related homeobox MLL4 0.006 myeloid/lymphoid or mixed-lineage leukemia 4 FAM48B1 0.006 hypothetical protein LOC100130302Human BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.